WPRIM Management System> DCMS> Clinical and Molecular Hepatology> 2014> 20> 4

Volume: 20 Issue: 4

1. Composite liver tumors: A radiologic-pathologic correlation. Page:406—410
2. Intrahepatic cholangiocarcinoma arising in Caroli's disease. Page:402—405
3. Reversible splenial lesion on the corpus callosum in nonfulminant hepatitis A presenting as encephalopathy. Page:398—401
4. A case of focal nodular hyperplasia with growth progression during pregnancy. Page:392—397
5. Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis. Page:384—391
6. Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension. Page:376—383
7. Predictors of spontaneous viral clearance and outcomes of acute hepatitis C infection. Page:368—375
8. Geographic differences in the epidemiological features of HCV infection in Korea. Page:361—367
9. Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?. Page:355—360
10. Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B. Page:347—354
11. Angiotensin receptor blocker add-on therapy in portal hypertension: To use angiotensin receptor blocker or not to use, that is the question. Page:345—346
12. Management of viral hepatitis in liver transplant recipients. Page:338—344
13. Cost-of-illness studies: concepts, scopes, and methods. Page:327—337